TitreAuteur(s)RevueAnnéeVol­umePagePMID
Con­tri­bu­tion and evo­lu­tion of blood cul­ture qual­i­ty indi­ca­tors.Car­dot Mar­tin, E ; Mar­t­in­uc­ci, P ; Lim­ou­sin, L ; Cahen, P ; Far­four, E ; Vasse, M & alAnn Biol Clin (Paris)201977331–33831219423
Rapid iden­ti­fi­ca­tion of Escherichia coli colonies from clin­i­cal sam­ple inoc­u­lat­ed on CHRO­Ma­gar Ori­en­ta­tion media (Bec­ton Dick­in­son).Far­four, E ; Hen­ry, A ; Razil­lard, A ; Car­dot, E ; Lim­ou­sin, L ; Cahen, P & alAnn Biol Clin (Paris)201977350–35231145076
Study of 109 Achro­mobac­ter spp. iso­lates from 9 French CF cen­tres reveals the cir­cu­la­tion of a mul­tire­sis­tant clone of A. xylosox­i­dans belong­ing to ST 137.Amoureux, L ; Sauge, J ; Sar­ret, B ; Lhoumeau, M ; Bajard, A ; Tetu, J & alJ Cyst Fibros201931104975
Con­tin­u­ous infu­sion of ceftolozane/tazobactam is asso­ci­at­ed with a high­er prob­a­bil­i­ty of tar­get attain­ment in patients infect­ed with Pseudomonas aerug­i­nosa.Pilmis, B ; Petit­jean, G ; Lesprit, P ; Lafau­rie, M ; El Helali, N ; Le Mon­nier, AEur J Clin Micro­bi­ol Infect Dis201931073653
The French glioblas­toma biobank (FGB): a nation­al clin­i­co­bi­o­log­i­cal data­base.Clavreul, A ; Soulard, G ; Lemée, JM ; Rig­ot, M ; Fab­bro-Per­ay, P ; Bauchet, L & alJ Transl Med20191713331014363
Eval­u­a­tion of the envi­ron­men­tal con­t­a­m­i­na­tion in micro­bi­ol­o­gy Which strat­e­gy to adopt?Far­four, E ; Lim­ou­sin, L ; Hen­ry, A ; Car­dot, E ; Karny­cheff, F ; Lecointe, D & alAnn Biol Clin (Paris)201977225–22830998201
[Tes­tic­u­lar germ cell tumors: Histopatho­log­i­cal and mol­e­c­u­lar fea­tures].Tourne, M ; Rad­ules­cu, C ; Allo­ry, YBull Can­cer2019106328–34130905378
Be care­ful about MICs to amox­i­cillin for patients with Strep­to­coc­ci-relat­ed infec­tive endo­cardi­tis.Pilmis, B ; Lourtet-Has­coët, J ; Bar­raud, O ; Piau, C ; Isnard, C ; Hery-Arnaud, G & alInt J Antimi­crob Agents201953850–85430851401
AIP-mutat­ed acromegaly resis­tant to first-gen­er­a­tion somato­statin analogs: long-term con­trol with pasireotide LAR in two patients.Daly, A ; Ros­to­myan, L ; Betea, D ; Bon­neville, JF ; Vil­la, C ; Pel­le­ga­ta, NS & alEndocr Con­nect201930851160
Mul­ti­ple recur­rences and risk of dis­ease pro­gres­sion in patients with pri­ma­ry low-grade (TaG1) non-mus­cle-inva­sive blad­der can­cer and with low and inter­me­di­ate EORTC-risk score.Simon, M ; Bos­set, PO ; Rouanne, M ; Ben­hamou, S ; Rad­ules­cu, C ; Molin­ié, V & alPLoS One201914e021172130811419
Mul­ti­cen­tre ran­domised con­trolled tri­al to inves­ti­gate use­ful­ness of the rapid diag­nos­tic βLAC­TA test per­formed direct­ly on bac­te­r­i­al cell pel­lets from res­pi­ra­to­ry, uri­nary or blood sam­ples for the ear­ly de-esca­la­tion of car­bapen­ems in sep­tic inten­sive care unit patients: the BLUE-Car­bA pro­to­col.Gar­nier, M ; Gal­lah, S ; Vimont, S ; Ben­z­er­ara, Y ; Labbe, V ; Con­stant, AL & alBMJ Open20199e02456130782909
Emer­gency Surgery in Acute Diver­ti­c­uli­tis: A Sys­tem­at­ic Review.Bey­er-Berjot, L ; Mag­giori, L ; Loiseau, D ; De Kor­win, JD ; Bon­gio­van­ni, JP ; Lesprit, P & alDis Colon Rec­tum201930694823
Clin­i­cal Rel­e­vance of EGFR- or KRAS-mutat­ed Sub­clones in Patients With Advanced Non-small-cell Lung Can­cer Receiv­ing Erlotinib in a French Prospec­tive Cohort (IFCT ERMETIC2 Cohort — Part 2).Beau-Fall­er, M ; Tex­i­er, M ; Blons, H ; Richard, N ; Escan­de, F ; Melaabi, S & alClin Lung Can­cer201920222–23030679079
F‑FDG PET/CT improves pre­op­er­a­tive lymph node stag­ing for patients with inva­sive blad­der can­cer.Girard, A ; Rouanne, M ; Taconet, S ; Rad­ules­cu, C ; Neuzil­let, Y ; Gir­ma, A & alEur Radi­ol2019294286–429330666449
Stro­mal lym­pho­cyte infil­tra­tion is asso­ci­at­ed with tumour inva­sion depth but is not prog­nos­tic in high-grade T1 blad­der can­cer.Rouanne, M ; Betari, R ; Rad­ules­cu, C ; Goubar, A ; Sig­nolle, N ; Neuzil­let, Y & alEur J Can­cer2019108111–11930654296
Impact of rapid diag­nos­tic tests on the man­age­ment of patients pre­sent­ing with Enter­obac­te­ri­aceae bac­teremia.Far­four, E ; Si Lar­bi, AG ; Car­dot, E ; Lim­ou­sin, L ; Math­on­net, D ; Cahen, P & alMed Mal Infect201949202–20730595423
Can the dura­tion of antibi­ot­ic ther­a­py be reduced with­out impair­ing its effi­ca­cy?Cas­tan, B ; Bon­net, É ; Gauz­it, R ; Lesprit, P ; Poitre­naud, D ; Win­ten­berg­er, CRev Prat201767703–70730512759
CNS inflam­ma­to­ry dis­or­der after con­cur­rent radio­ther­a­py-temo­zolo­mide and nivolum­ab in a glioblas­toma patient.Di Ste­fano, AL ; Sava­tovsky, J ; Feu­vret, L ; Vil­la, C ; Reina, V ; Pha, M & alNeu­ro Oncol201921139–14130476174
The 2016 World Health Orga­ni­za­tion clas­si­fi­ca­tion of tumours of the cen­tral ner­vous sys­tem.Vil­la, C ; Miquel, C ; Moss­es, D ; Bernier, M ; Di Ste­fano, ALPresse Med201847e187-e20030449638
Hyper­me­thy­la­tor Phe­no­type and Ectopic GIP Recep­tor in GNAS Muta­tion-Neg­a­tive Soma­totropino­mas.Hage, M ; Chaligné, R ; Viengchare­un, S ; Vil­la, C ; Sale­nave, S ; Bouli­gand, J & alJ Clin Endocrinol Metab20191041777–178730376114
Sex steroids in serum and pro­sta­t­ic tis­sue of human can­cer­ous prostate (STERKPROSER tri­al).Meu­nier, ME ; Neuzil­let, Y ; Ray­naud, JP ; Rad­ules­cu, C ; Ghoneim, T ; Fiet, J & alProstate201979272–28030370569
Aggres­sive­ness of Local­ized Prostate Can­cer: the Key Val­ue of Testos­terone Defi­cien­cy Eval­u­at­ed by Both Total and Bioavail­able Testos­terone: Andro­Can Study Results.Neuzil­let, Y ; Ray­naud, JP ; Drey­fus, JF ; Rad­ules­cu, C ; Rouanne, M ; Schnei­der, M & alHorm Can­cer20191036–4430293206
Somato­statin recep­tor 2A pro­tein expres­sion char­ac­ter­izes anaplas­tic oligo­den­drogliomas with favor­able out­come.Appay, R ; Tabouret, E ; Touat, M ; Car­pen­tier, C ; Col­in, C ; Ducray, F & alActa Neu­ropathol Com­mun201868930193580
-mutant gan­gli­oglioma.Touat, M ; Gratieux, J ; Con­dette Auli­ac, S ; Sejean, K ; Aldea, S ; Sava­tovsky, J & alNeu­rol­o­gy201891523–52530120137
High fre­quen­cy of anti-pro­tein Z anti­bod­ies in patients with anti­car­di­olipin anti­bod­ies.Andria­mandim­bisoa, TH ; Kahn, JE ; Bour­dain, F ; François, D ; Vasse, MImmuno­bi­ol­o­gy2018223772–77630115377
Asso­ci­a­tion between genet­ic poly­mor­phisms and plat­inum-induced oto­tox­i­c­i­ty in chil­dren.Lui, G ; Bouaz­za, N ; Denoyelle, F ; Moine, M ; Brugières, L ; Chastag­n­er, P & alOnco­tar­get2018930883–3089330112115
Machine Learn­ing for Bet­ter Prog­nos­tic Strat­i­fi­ca­tion and Dri­ver Gene Iden­ti­fi­ca­tion Using Somat­ic Copy Num­ber Vari­a­tions in Anaplas­tic Oligo­den­droglioma.Rosen­berg, S ; Ducray, F ; Alen­torn, A ; Dehais, C ; Elarouci, N ; Kamoun, A & alOncol­o­gist2018231500–151030018130
ATP6V0A2-relat­ed cutis laxa in 10 nov­el patients: Focus on clin­i­cal vari­abil­i­ty and expan­sion of the phe­no­type.Beyens, A ; Moreno-Artero, E ; Bode­mer, C ; Cox, H ; Gezdiri­ci, A ; Yil­maz Gulec, E & alExp Der­ma­tol201829952037
-Har­bor­ing Plas­mid Pre­dict Embolism in Infec­tive Endo­cardi­tis.Rasi­gade, JP ; Leclère, A ; Alla, F ; Tessier, A ; Bes, M ; Lechiche, C & alFront Cell Infect Micro­bi­ol2018818729938201
A recur­rent point muta­tion in PRKCA is a hall­mark of chor­doid gliomas.Rosen­berg, S ; Sime­ono­va, I ; Bielle, F ; Ver­reault, M ; Bance, B ; Le Roux, I & alNat Com­mun20189237129915258
[Does the delay from prostate biop­sy to rad­i­cal prosta­te­c­to­my influ­ence the risk of bio­chem­i­cal recur­rence?]Meu­nier, ME ; Neuzil­let, Y ; Rad­ules­cu, C ; Cher­bon­nier, C ; Hervé, JM ; Rouanne, M & alProg Urol201828475–48129907495
Clopi­do­grel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.John­ston, SC ; Eas­t­on, JD ; Far­rant, M ; Barsan, W ; Con­wit, RA ; Elm, JJ & alN Engl J Med2018379215–22529766750
From arte­r­i­al stiff­ness to kid­ney graft microvas­cu­la­ture: Mor­tal­i­ty and graft sur­vival with­in a cohort of 220 kid­ney trans­plant recip­i­ents.Ched­dani, L ; Rad­ules­cu, C ; Chaignon, M ; Kar­ras, A ; Neuzil­let, Y ; Duong, JP & alPLoS One201813e019592829723212
A 4.5‑Year With­in-Patient Evo­lu­tion of a Col­istin-Resis­tant Kleb­siel­la pneu­mo­ni­ae Car­bapen­e­mase-Pro­duc­ing K. pneu­mo­ni­ae Sequence Type 258.Jous­set, AB ; Bon­nin, RA ; Rosin­s­ki-Chupin, I ; Girlich, D ; Cuzon, G ; Cabanel, N & alClin Infect Dis2018671388–139429688339
Suc­cess­ful pul­monary arte­r­i­al emboliza­tion fol­lowed by cura­tive surgery for a lep­idic pre­dom­i­nant lung ade­no­car­ci­no­ma with severe hypox­emia.Sebane, L ; El-Haj­jam, M ; Puyo, P ; Longchampt, E ; Giroux Lep­rieur, EBMC Surg2018182029631581
[Imple­men­ta­tion and assess­ment of anti­cancer drugs batch prepa­ra­tion cir­cuit in a teach­ing hos­pi­tal].Moine, M ; Hachon, L ; Sankhare, D ; Ade, A ; Made­laine, I ; Jour­dan, NAnn Pharm Fr201876306–32029625693
Clin­i­cal Assess­ment of a Nocar­dia PCR-Based Assay for Diag­no­sis of Nocar­dio­sis.Rouza­ud, C ; Rodriguez-Nava, V ; Catherinot, E ; Méchaï, F ; Berg­eron, E ; Far­four, E & alJ Clin Micro­bi­ol20185629563199
[Tim‑3: a nov­el bio­mark­er and ther­a­peu­tic tar­get in oncol­o­gy].Granier, C ; Gey, A ; Dar­i­ane, C ; Mejean, A ; Tim­sit, MO ; Blanc, C & alMed Sci (Paris)201834231–23729547109
IDH2 muta­tions are com­mon­ly asso­ci­at­ed with 1p/19q codele­tion in dif­fuse adult gliomas.Appay, R ; Tabouret, E ; Macagno, N ; Touat, M ; Car­pen­tier, C ; Col­in, C & alNeu­ro Oncol201820716–71829522183
[Imple­men­ta­tion of a remote oncol­o­gy-mon­i­tor­ing pro­gram for can­cer patients in out­pa­tient care unit: A major chal­lenge for the dif­fer­ent actors].Peyrilles, E ; Lep­age-Sey­doux, C ; Sejean, K ; Bonan, BBull Can­cer2018105357–36729499998
out­breaks: a 6‑year prospec­tive study in a French mul­ti­hos­pi­tal insti­tu­tion, Jan­u­ary 2010 to Decem­ber 2015.Fournier, S ; Desen­fant, L ; Mon­teil, C ; Nion-Huang, M ; Richard, C ; Jar­li­er, VEuro Sur­veill20182329486831
Genom­ic Alter­ations and Com­plex Sub­clon­al Archi­tec­ture in Spo­radic GH-Secret­ing Pitu­itary Ade­no­mas.Hage, M ; Viengchare­un, S ; Brunet, E ; Vil­la, C ; Pineau, D ; Bouli­gand, J & alJ Clin Endocrinol Metab20181031929–193929474559
mouse mod­el.Bernard, V ; Vil­la, C ; Auguste, A ; Lamothe, S ; Guil­lou, A ; Mar­tin, A & alOnco­tar­get201896144–615529464061
Iden­ti­fi­ca­tion of nov­el recur­rent ETV6-IgH fusions in pri­ma­ry cen­tral ner­vous sys­tem lym­phoma.Bruno, A ; Labreche, K ; Dani­au, M ; Bois­se­li­er, B ; Gau­chotte, G ; Roy­er-Per­ron, L & alNeu­ro Oncol2018201092–110029432597
Gene Con­fer a Pre­dis­po­si­tion to Metasta­t­ic Para­gan­gliomas.Buf­fet, A ; Morin, A ; Cas­tro-Vega, LJ ; Habarou, F ; Lussey-Lep­outre, C ; Letouzé, E & alCan­cer Res2018781914–192229431636
Tran­scrip­tom­ic def­i­n­i­tion of mol­e­c­u­lar sub­groups of small round cell sar­co­mas.Wat­son, S ; Per­rin, V ; Guille­mot, D ; Rey­naud, S ; Coin­dre, JM ; Karan­ian, M & alJ Pathol201824529–4029431183
[A pecu­liar intra-uter­ine lesion: Inflam­ma­to­ry myofi­brob­las­tic tumor (IMT)].Kesrouani, C ; Zemoura, L ; Laé, MAnn Pathol201838143–14629397221
Uri­nary tract infec­tion after acute stroke: Impact of indwelling uri­nary catheter­i­za­tion and assess­ment of catheter-use prac­tices in French stroke cen­ters.Net, P ; Karny­cheff, F ; Vasse, M ; Bour­dain, F ; Bonan, B ; Laper­gue, BRev Neu­rol (Paris)2018174145–14929395254
Impaired Trans­fer­rin Recep­tor Palmi­toy­la­tion and Recy­cling in Neu­rode­gen­er­a­tion with Brain Iron Accu­mu­la­tion.Drecourt, A ; Bab­dor, J ; Dus­siot, M ; Petit, F ; Goudin, N ; Gar­fa-Tra­oré, M & alAm J Hum Genet2018102266–27729395073
Acute hepati­tis A break­through in MSM in Paris area: imple­men­ta­tion of tar­get­ed hepati­tis A virus vac­cine in a con­text of vac­cine short­age.Far­four, E ; Lesprit, P ; Chan Hew Wai, A ; Maza­ux, L ; Fourn, E ; Majer­holc, C & alAIDS201832531–53229381561
Blood Gene Expres­sion Pre­dicts Bron­chi­oli­tis Oblit­er­ans Syn­drome.Dan­ger, R ; Roy­er, PJ ; Reboul­leau, D ; Durand, E ; Loy, J ; Tis­sot, A & alFront Immunol20178184129375549
The True Abla­tion Effect of Holmi­um YAG Laser on Soft Tis­sue.Emil­iani, E ; Tal­so, M ; Had­dad, M ; Pouliquen, C ; Der­man, J ; Côté, JF & alJ Endourol201832230–23529357684
Are infec­tion spe­cial­ists rec­om­mend­ing short antibi­ot­ic treat­ment dura­tions? An ESCMID inter­na­tion­al cross-sec­tion­al sur­vey.Mache­da, G ; Dyar, OJ ; Luc, A ; Beovic, B ; Béraud, G ; Cas­tan, B & alJ Antimi­crob Chemoth­er2018731084–109029346568
Expe­ri­ences and per­spec­tives of imple­ment­ing antimi­cro­bial stew­ard­ship in five French hos­pi­tals: a qual­i­ta­tive study.Per­ozziel­lo, A ; Routelous, C ; Cha­rani, E ; Tru­el, A ; Bir­gand, G ; Yaz­dan­panah, Y & alInt J Antimi­crob Agents201851829–83529339297
Human Immun­od­e­fi­cien­cy Virus Type 1 Group O Infec­tion in France: Clin­i­cal Fea­tures and Immunovi­ro­log­i­cal Response to Anti­retro­vi­rals.Unal, G ; Alessan­dri-Gradt, E ; Leoz, M ; Pavie, J ; Lefèvre, C ; Pan­jo, H & alClin Infect Dis2018661785–179329272369
Pitu­itary Lesion of Unknown Ori­gin: Think Epithe­lioid Angiosar­co­ma.Bricaire, L ; Vil­la, C ; Brière, M ; Edjlali, M ; Larousserie, F ; d””Ussel, M & alJ Endocr Soc2017172–7429264447
FAM13A is a mod­i­fi­er gene of cys­tic fibro­sis lung phe­no­type reg­u­lat­ing rhoa activ­i­ty, actin cytoskele­ton dynam­ics and epithe­lial-mes­enchy­mal tran­si­tion.Cor­vol, H ; Rous­se­let, N ; Thomp­son, KE ; Berdah, L ; Cot­tin, G ; Fous­sig­niere, T & alJ Cyst Fibros201817190–20329239766
Prog­estin-asso­ci­at­ed shift of menin­gioma muta­tion­al land­scape.Peyre, M ; Gail­lard, S ; de Mar­cel­lus, C ; Giry, M ; Bielle, F ; Vil­la, C & alAnn Oncol201829681–68629206892
High­ly spe­cif­ic deter­mi­na­tion of IDH sta­tus using edit­ed in vivo mag­net­ic res­o­nance spec­troscopy.Bran­zoli, F ; Di Ste­fano, AL ; Capelle, L ; Ottolenghi, C ; Val­abrègue, R ; Deelc­hand, DK & alNeu­ro Oncol201820907–91629126125
Olfac­to­ry Epithe­lial Hamar­toma: A New Sub­type of Sinonasal Hamar­toma.Kos­sai, M ; El Zein, S ; Wassef, M ; Guichard, JP ; Pouliquen, C ; Her­man, P & alAm J Surg Pathol2018429–1729076871
Dif­fuse gliomas with FGFR3-TACC3 fusion have char­ac­ter­is­tic histopatho­log­i­cal and mol­e­c­u­lar fea­tures.Bielle, F ; Di Ste­fano, AL ; Mey­ronet, D ; Pic­ca, A ; Vil­la, C ; Bernier, M & alBrain Pathol201828674–68328976058
Increase in sex­u­al­ly trans­mit­ted infec­tions in a cohort of out­pa­tient HIV-pos­i­tive men who have sex with men in the Parisian region.Far­four, E ; Dimi, S ; Majer­holc, C ; Fourn, E ; Séné, T ; Chai­da, MB & alMed Mal Infect201747490–49328943174
Sex­u­al steroids in serum and pro­sta­t­ic tis­sue of human non-can­cer­ous prostate (STERPROSER tri­al).Neuzil­let, Y ; Ray­naud, JP ; Rad­ules­cu, C ; Fiet, J ; Giton, F ; Drey­fus, JF & alProstate2017771512–151928905453
Autism spec­trum dis­or­ders in pro­pi­onic acidemia patients.de la Bâtie, CD ; Bar­bi­er, V ; Roda, C ; Brassier, A ; Arnoux, JB ; Valayannopou­los, V & alJ Inher­it Metab Dis201841623–62928856627
Lung can­cer in renal trans­plant recip­i­ents: A case-con­trol study.Rousseau-Gazan­iol, C ; Fraboulet, S ; Coud­erc, LJ ; Kreis, H ; Borie, R ; Tri­cot, L & alLung Can­cer201711196–10028838407
Pre­dic­tors of pre-pro­ce­dur­al con­cen­tra­tions of direct oral anti­co­ag­u­lants: a prospec­tive mul­ti­cen­tre study.Godi­er, A ; Dincq, AS ; Mar­tin, AC ; Radu, A ; Leblanc, I ; Antona, M & alEur Heart J2017382431–243928821169
Nat­ur­al His­to­ry of Local­ized and Local­ly Advanced Atyp­i­cal Lung Car­ci­noids after Com­plete Resec­tion: A Joined French-Ital­ian Ret­ro­spec­tive Mul­ti­cen­ter Study.Mar­ciel­lo, F ; Merci­er, O ; Fer­ol­la, P ; Scoazec, JY ; Filos­so, PL ; Chape­lier, A & alNeu­roen­docrinol­o­gy2018106264–27328813709
[Antibi­ot­ic stew­ard­ship: A 2017 update].Cas­tan, B ; Lesprit, P ; Alfan­dari, S ; Bon­net, E ; Dia­man­tis, S ; Gauz­it, R & alMed Mal Infect201747439–44228781198
Sim­ple Scor­ing Sys­tem to Pre­dict In-Hos­pi­tal Mor­tal­i­ty After Surgery for Infec­tive Endo­cardi­tis.Gat­ti, G ; Per­rot­ti, A ; Oba­dia, JF ; Duval, X ; Iung, B ; Alla, F & alJ Am Heart Assoc2017628729412
Air­way micro­bio­ta sig­nals ana­bol­ic and cata­bol­ic remod­el­ing in the trans­plant­ed lung.Mouraux, S ; Bernasconi, E ; Pat­ta­roni, C ; Kout­sok­era, A ; Aubert, JD ; Claus­tre, J & alJ Aller­gy Clin Immunol2018141718–729.e728729000
Exist­ing report­ing guide­lines for clin­i­cal tri­als are not com­plete­ly rel­e­vant for implantable med­ical devices: a sys­tem­at­ic review.Motte, AF ; Dial­lo, S ; van den Brink, H ; Château­vieux, C ; Ser­ra­no, C ; Naud, C & alJ Clin Epi­demi­ol201791111–12028728922
gene are a nov­el cause of Cushing”s dis­ease.Hernán­dez-Ramírez, LC ; Gam, R ; Valdés, N ; Lodish, MB ; Pankratz, N ; Bal­sa­lo­bre, A & alEndocr Relat Can­cer201724379–39228533356
Ketone Bod­ies as a Pos­si­ble Adju­vant to Keto­genic Diet in PDHc Defi­cien­cy but Not in GLUT1 Defi­cien­cy.Habarou, F ; Bahi-Buis­son, N ; Lebig­ot, E ; Pon­toizeau, C ; Abi-Warde, MT ; Brassier, A & alJIMD Rep20183853–5928510035
Temo­zolo­mide treat­ment can improve over­all sur­vival in aggres­sive pitu­itary tumors and pitu­itary car­ci­no­mas.Lasolle, H ; Cortet, C ; Castinet­ti, F ; Cloix, L ; Caron, P ; Dele­mer, B & alEur J Endocrinol2017176769–77728432119
Glea­son Score with­in Prostate Abnor­mal Areas Defined by Mul­ti­para­met­ric Mag­net­ic Res­o­nance Imag­ing Did Not Vary Accord­ing to the PIRADS Score.Slaoui, H ; Neuzil­let, Y ; Ghoneim, T ; Rouanne, M ; Abdou, A ; Lugagne-Delpon, PM & alUrol Int201799156–16128391284
Effi­ca­cy of endo­scop­ic endonasal transsphe­noidal surgery for Cushing”s dis­ease in 230 patients with pos­i­tive and neg­a­tive MRI.Cebu­la, H ; Baus­sart, B ; Vil­la, C ; Assié, G ; Boulin, A ; Fou­bert, L & alActa Neu­rochir (Wien)20171591227–123628281008
Pro­pos­al for short­er antibi­ot­ic ther­a­pies.Win­ten­berg­er, C ; Guery, B ; Bon­net, E ; Cas­tan, B ; Cohen, R ; Dia­man­tis, S & alMed Mal Infect20174792–14128279491
From pitu­itary ade­no­ma to pitu­itary neu­roen­docrine tumor (Pit­NET): an Inter­na­tion­al Pitu­itary Pathol­o­gy Club pro­pos­al.Asa, SL ; Casar-Boro­ta, O ; Chan­son, P ; Del­grange, E ; Earls, P ; Ezzat, S & alEndocr Relat Can­cer201724C5-C828264912
Gan­glio­cy­toma: out­come of a rare silent pitu­itary tumour.Donadille, B ; Vil­la, C ; Gail­lard, S ; Christin-Maitre, SBMJ Case Rep2017201728232376
Com­plex for­ma­tion with pentraxin‑2 reg­u­lates fac­tor X plas­ma lev­els and macrophage inter­ac­tions.Muczyn­s­ki, V ; Aymé, G ; Reg­nault, V ; Vasse, M ; Borgel, D ; Legendre, P & alBlood20171292443–245428213380
Clin­i­cal fea­tures and prog­nos­tic fac­tors of lis­te­rio­sis: the MONALISA nation­al prospec­tive cohort study.Char­li­er, C ; Per­rodeau, É ; Lecler­cq, A ; Cazenave, B ; Pilmis, B ; Hen­ry, B & alLancet Infect Dis201717510–51928139432
Trans­d­if­fer­en­ti­a­tion of Neu­roen­docrine Cells: Gan­glio­cy­toma Asso­ci­at­ed With Two Pitu­itary Ade­no­mas of Dif­fer­ent Lin­eage in MEN1.Sergeant, C ; Jublanc, C ; Lecler­cq, D ; Boch, AL ; Bielle, F ; Raverot, G & alAm J Surg Pathol201741849–85328079577
T Cells Pro­mote Bronchial Epithe­lial Cell Secre­tion of Matrix Metalloproteinase‑9 via a C‑C Chemokine Recep­tor Type 2 Path­way: Impli­ca­tions for Chron­ic Lung Allo­graft Dys­func­tion.Pain, M ; Roy­er, PJ ; Loy, J ; Girardeau, A ; Tis­sot, A ; Lacoste, P & alAm J Trans­plant2017171502–151427982503
Pre­dom­i­nance of health­care-asso­ci­at­ed cas­es among episodes of com­mu­ni­ty-onset bac­ter­aemia due to extend­ed-spec­trum β‑lac­ta­mase-pro­duc­ing Enter­obac­te­ri­aceae.Zahar, JR ; Lesprit, P ; Ruck­ly, S ; Eden, A ; Hikom­bo, H ; Bernard, L & alInt J Antimi­crob Agents20174967–7327890442
T Cells Cor­re­lates with Poor Clin­i­cal Out­come in Renal Cell Car­ci­no­ma.Granier, C ; Dar­i­ane, C ; Combe, P ; Verkarre, V ; Urien, S ; Badoual, C & alCan­cer Res2017771075–108227872087
[Antibi­ot­ic stew­ard­ship: What”s new?]Cas­tan, B ; Lesprit, P ; Alfan­dari, S ; Bon­net, E ; Dia­man­tis, S ; Gauz­it, R & alMed Mal Infect201646403–40527856081
Tumoral het­ero­gene­ity of breast can­cer.Roulot, A ; Héquet, D ; Guine­bretière, JM ; Vin­cent-Salomon, A ; Lere­bours, F ; Dubot, C & alAnn Biol Clin (Paris)201674653–66027848916
The impact of low-fre­quen­cy, low-force cyclic stretch­ing of human bronchi on air­way respon­sive­ness.Le Guen, M ; Grassin-Delyle, S ; Naline, E ; Buen­es­ta­do, A ; Brol­lo, M ; Longchampt, E & alRespir Res20161715127842540
How to facil­i­tate ear­ly diag­no­sis of CNS involve­ment in malig­nant lym­phoma.Kor­fel, A ; Nowosiel­s­ki, M ; Par­do-Moreno, J ; Penalver, FJ ; Buda, G ; Ben­nani, H & alExpert Rev Hema­tol201691081–109127677656
[A hybrid lesion: Low-grade fibromyx­oid sar­co­ma (LGFMS) and scle­ros­ing epithe­lioid fibrosar­co­ma (SEF)].Kesrouani, C ; Zemoura, L ; Trassard, M ; Laé, MAnn Pathol201636351–35427641819
BIRC5 (sur­vivin): a pejo­ra­tive prog­nos­tic mark­er in stage II/III breast can­cer with no response to neoad­ju­vant chemother­a­py.Hamy, AS ; Bieche, I ; Lehmann-Che, J ; Scott, V ; Bertheau, P ; Guine­bretière, JM & alBreast Can­cer Res Treat2016159499–51127592112
Tumor cells with neu­ronal inter­me­di­ate prog­en­i­tor fea­tures define a sub­group of 1p/19q co-delet­ed anaplas­tic gliomas.Bielle, F ; Ducray, F ; Mokhtari, K ; Dehais, C ; Adle-Bias­sette, H ; Car­pen­tier, C & alBrain Pathol201727567–57927543943
Involve­ment of NK Cells and NKp30 Path­way in Anti­syn­thetase Syn­drome.Hervi­er, B ; Perez, M ; Allen­bach, Y ; Dev­il­liers, H ; Cohen, F ; Uzun­han, Y & alJ Immunol20161971621–3027511738
How well Informed are Can­cer Patients Pri­or to a Life Cycle of Injectable Chemother­a­py Drug Treat­ment?Jobard, M ; Sejean, K ; Lep­age-Sey­doux, C ; Bonan, BJ Can­cer Educ20183374–8227492425
Rad­i­cal Cari­nal Resec­tion for a Glom­ic Tumor.Bel­li­er, J ; Sage, E ; Gonin, F ; Longchampt, E ; Chape­lier, AAnn Tho­rac Surg2016102e143‑527449451
Biopatho­log­i­cal Sig­nif­i­cance of TLR9 Expres­sion in Can­cer Cells and Tumor Microen­vi­ron­ment Across Inva­sive Breast Car­ci­no­mas Sub­types.Meseure, D ; Vach­er, S ; Drak Alsi­bai, K ; Trassard, M ; Nico­las, A ; Leclere, R & alCan­cer Microen­v­i­ron20169107–11827392414
An inter­na­tion­al study com­par­ing con­ven­tion­al ver­sus mRNA lev­el test­ing (Tar­get­Print) for ER, PR, and HER2 sta­tus of breast can­cer.Wes­sel­ing, J ; Tin­ter­ri, C ; Sapino, A ; Zan­conati, F ; Lutke-Holzik, M ; Nguyen, B & alVir­chows Arch2016469297–30427377889
Com­mu­ni­ty-acquired Clostrid­i­um dif­fi­cile infec­tions in emer­gency depart­ments.Lefevre-Tan­tet-Etchebarne, D ; Sivadon-Tardy, V ; Davi­do, B ; Bouc­hand, F ; Grenet, J ; Far­four, E & alMed Mal Infect201646372–37927377443
Zole­dronate in com­bi­na­tion with chemother­a­py and surgery to treat osteosar­co­ma (OS2006): a ran­domised, mul­ti­cen­tre, open-label, phase 3 tri­al.Piper­no-Neu­mann, S ; Le Deley, MC ; Rédi­ni, F ; Pac­que­ment, H ; Marec-Bérard, P ; Petit, P & alLancet Oncol2016171070–108027324280
Char­ac­ter­i­za­tion of GPR101 tran­script struc­ture and expres­sion pat­terns.Triv­el­lin, G ; Bjelob­a­ba, I ; Daly, AF ; Lar­co, DO ; Palmeira, L ; Faucz, FR & alJ Mol Endocrinol20165797–11127282544
Hyper­cor­ti­solism due to a Pitu­itary Ade­no­ma Asso­ci­at­ed with Beck­with-Wiede­mann Syn­drome.Brioude, F ; Nico­las, C ; Marey, I ; Gail­lard, S ; Bernier, M ; Das Neves, C & alHorm Res Pae­di­a­tr201686206–21127255538
Prepar­ing and admin­is­ter­ing injectable antibi­otics: How to avoid play­ing God.Longuet, P ; Lecap­i­taine, AL ; Cas­sard, B ; Batista, R ; Gauz­it, R ; Lesprit, P & alMed Mal Infect201646242–6827112521
Mechan­i­cal Sig­nals Inhib­it Growth of a Graft­ed Tumor In Vivo: Proof of Con­cept.Brossel, R ; Yahi, A ; David, S ; Moreno Velasquez, L ; Guine­bretière, JMPLoS One201611e015288527100674
Inte­grat­ed mul­ti-omics analy­sis of oligo­den­droglial tumours iden­ti­fies three sub­groups of 1p/19q co-delet­ed gliomas.Kamoun, A ; Idbaih, A ; Dehais, C ; Elarouci, N ; Car­pen­tier, C ; Letouzé, E & alNat Com­mun201671126327090007
[Shall all lob­u­lar intraep­ithe­lial neo­pla­sia diag­nosed on image-guid­ed biop­sy require a sur­gi­cal man­age­ment?].Fis­ch­er-Hun­singer, M ; Guine­bretière, JM ; Las­ry, S ; Langer, A ; Berment, H ; Nek­ka, I & alBull Can­cer2016103421–3327084199
Anti-Tumoral Effects of Anti-Prog­estins in a Patient-Derived Breast Can­cer Xenograft Mod­el.Esber, N ; Cher­bon­nier, C ; Resche-Rigon, M ; Hamze, A ; Ala­mi, M ; Fagart, J & alHorm Can­cer20167137–4726941094
Three Rounds of Exter­nal Qual­i­ty Assess­ment in France to Eval­u­ate the Per­for­mance of 28 Plat­forms for Mul­ti­para­met­ric Mol­e­c­u­lar Test­ing in Metasta­t­ic Col­orec­tal and Non-Small Cell Lung Can­cer.Dequek­er, EM ; Kep­pens, C ; Egele, C ; Delen, S ; Lamy, A ; Lemoine, A & alJ Mol Diagn201618205–1426752307
Decreased lev­els of pro­co­ag­u­lant phos­pho­lipids in bleed­ing patients treat­ed by vit­a­min K antag­o­nists.Math­ieu, E ; Van Dreden, P ; Aulagnier, J ; Grusse, M ; Drey­fus, JF ; François, D & alThromb Res201613736–4026632514
Aggres­sive tumor growth and clin­i­cal evo­lu­tion in a patient with X‑linked acro-gigan­tism syn­drome.Naves, LA ; Daly, AF ; Dias, LA ; Yuan, B ; Zakir, JC ; Bar­ra, GB & alEndocrine201651236–4426607152
Pim kinas­es mod­u­late resis­tance to FLT3 tyro­sine kinase inhibitors in FLT3-ITD acute myeloid leukemia.Green, AS ; Maciel, TT ; Hos­pi­tal, MA ; Yin, C ; Mazed, F ; Townsend, EC & alSci Adv20151e150022126601252
[Not Avail­able].Salomon, L ; Bas­tu­ji-Garin, S ; Maze­rolles, C ; Devonec, M ; Soulie, M ; Benoit, G & alProg Urol201525792–326544348
[Not Avail­able].Net, P ; Karny­cheff, F ; Butreau, M ; Lesprit, P ; Szeke­ly, B ; Vasse, M & alProg Urol201525776–726544320
[Not Avail­able].Neuzil­let, Y ; Jar­ry, L ; Rad­ules­cu, C ; Rouanne, M ; Lebret, TProg Urol201525770–126544306
[Not Avail­able].Neuzil­let, Y ; Ray­naud, J ; Pichon, A ; Ghoneim, T ; Lebret, T ; Rad­ules­cu, C & alProg Urol20152574126544247
Draft Genome Sequences of Two Species of “Dif­fi­cult-to-Iden­ti­fy” Human-Path­o­gen­ic Corynebac­te­ria: Impli­ca­tions for Bet­ter Iden­ti­fi­ca­tion Tests.Pacheco, LG ; Mat­tos-Guaral­di, AL ; San­tos, CS ; Veras, AA ; Guimarães, LC ; Abreu, V & alJ Genomics2015382–426516374
Car­bapen­em use in French hos­pi­tals: A nation­wide sur­vey at the patient lev­el.Gauz­it, R ; Pean, Y ; Alfan­dari, S ; Bru, JP ; Bedos, JP ; Rabaud, C & alInt J Antimi­crob Agents201546707–1226508585
Car­diac Dis­eases Fol­low­ing Child­hood Can­cer Treat­ment: Cohort Study.Had­dy, N ; Dial­lo, S ; El-Fayech, C ; Schwartz, B ; Pein, F ; Hawkins, M & alCir­cu­la­tion201613331–826487757
Pre­op­er­a­tive low serum testos­terone is asso­ci­at­ed with high-grade prostate can­cer and an increased Glea­son score upgrad­ing.Pichon, A ; Neuzil­let, Y ; Bot­to, H ; Ray­naud, JP ; Rad­ules­cu, C ; Molin­ié, V & alProstate Can­cer Pro­sta­t­ic Dis201518382–726439747
Com­par­a­tive effec­tive­ness of imme­di­ate anti­retro­vi­ral ther­a­py ver­sus CD4-based ini­ti­a­tion in HIV-pos­i­tive indi­vid­u­als in high-income coun­tries: obser­va­tion­al cohort study.Lodi, S ; Phillips, A ; Logan, R ; Olson, A ; Costagli­o­la, D ; Abgrall, S & alLancet HIV20152e335-4326423376
[Euro­pean Antibi­ot­ic Aware­ness Day: What is new in France?].Pul­ci­ni, C ; Alfan­dari, S ; Ballereau, F ; Bon­net, E ; Bruneel, F ; Cas­tan, B & alMed Mal Infect201545345–726411783
Allel­ic loss of 9p21.3 is a prog­nos­tic fac­tor in 1p/19q codelet­ed anaplas­tic gliomas.Alen­torn, A ; Dehais, C ; Ducray, F ; Car­pen­tier, C ; Mokhtari, K ; Figarel­la-Branger, D & alNeu­rol­o­gy2015851325–3126385879
Prog­nos­tic impact of dis­crepant Ki67 and mitot­ic index on hor­mone recep­tor-pos­i­tive, HER2-neg­a­tive breast car­ci­no­ma.Rossi, L ; Laas, E ; Mal­lon, P ; Vin­cent-Salomon, A ; Guine­bretiere, JM ; Lere­bours, F & alBr J Can­cer2015113996‑100226379080
Val­ue of positron emis­sion tomog­ra­phy in diag­nos­ing syn­chro­nous penile metas­ta­sis from urothe­lial blad­der can­cer.Rouanne, M ; Alham­ma­di, A ; Vilain, D ; Rad­ules­cu, C ; Lebret, TWorld J Surg Oncol20151327626376852
[Cyclosporine eye drops: A 4‑year ret­ro­spec­tive study (2009–2013)].Kauss Hor­neck­er, M ; Charles Weber, S ; Bran­de­ly Piat, ML ; Dar­rodes, M ; Jomaa, K ; Chast, FJ Fr Oph­tal­mol201538700–826371985
Extend­ed-spec­trum beta-lac­ta­mase-pro­duc­ing Enter­obac­te­ri­aceae (ESBL-PE) infec­tions: are car­bapen­em alter­na­tives achiev­able in dai­ly prac­tice?Pilmis, B ; Delo­ry, T ; Groh, M ; Weiss, E ; Emiri­an, A ; Lecuy­er, H & alInt J Infect Dis20153962–726327124
Prospec­tive pilot study of high-dose (10 mg/kg/day) lipo­so­mal ampho­tericin B (L‑AMB) for the ini­tial treat­ment of mucormy­co­sis.Lanternier, F ; Poiree, S ; Elie, C ; Gar­cia-Her­moso, D ; Bak­ouboula, P ; Sit­bon, K & alJ Antimi­crob Chemoth­er2015703116–2326316385
Co-expres­sion of tono­plast Cation/H(+) antiporter and H(+)-pyrophosphatase from xero­phyte Zygo­phyl­lum xan­thoxy­lum improves alfal­fa plant growth under salin­i­ty, drought and field con­di­tions.Bao, AK ; Du, BQ ; Touil, L ; Kang, P ; Wang, QL ; Wang, SMPlant Biotech­nol J201614964–7526268400
Patho­log­i­cal Char­ac­ter­is­tics of Both Tumors in Bifo­cal and Bicen­tric Breast Can­cer.Mos­bah, R ; Rouzi­er, R ; Guine­bretière, JM ; Fal­cou, MC ; Stevens, D ; Héquet, DAnti­cancer Res2015355111–626254415
Hos­pi­tal cost of Clostrid­i­um dif­fi­cile infec­tion includ­ing the con­tri­bu­tion of recur­rences in French acute-care hos­pi­tals.Le Mon­nier, A ; Dubur­cq, A ; Zahar, JR ; Corvec, S ; Guil­lard, T ; Cat­toir, V & alJ Hosp Infect201591117–2226253518
Deep brush-based cytol­ogy in ton­sils resect­ed for benign dis­eases.Franceschi, S ; Combes, JD ; Dal­stein, V ; Cau­droy, S ; Clif­ford, G ; Gheit, T & alInt J Can­cer20151372994–926111735
Man­age­ment of clin­i­cal­ly non-func­tion­ing pitu­itary ade­no­ma.Chan­son, P ; Raverot, G ; Castinet­ti, F ; Cortet-Rudel­li, C ; Gal­land, F ; Sale­nave, SAnn Endocrinol (Paris)201576239–4726072284
Non-func­tion­ing pitu­itary ade­no­ma: when and how to oper­ate? What patho­log­ic cri­te­ria for typ­ing?Castinet­ti, F ; Dufour, H ; Gail­lard, S ; Jouan­neau, E ; Vasil­je­vic, A ; Vil­la, C & alAnn Endocrinol (Paris)201576220–726070464
TCF12 is mutat­ed in anaplas­tic oligo­den­droglioma.Labreche, K ; Sime­ono­va, I ; Kamoun, A ; Gleize, V ; Chubb, D ; Letouzé, E & alNat Com­mun20156720726068201
Cryp­to­coc­co­sis Serotypes Impact Out­come and Pro­vide Evi­dence of Cryp­to­coc­cus neo­for­mans Spe­ci­a­tion.Desnos-Ollivi­er, M ; Patel, S ; Raoux-Bar­bot, D ; Heit­man, J ; Dromer, FMBio20156e0031126060271
Obe­si­ty and hypog­o­nadism are asso­ci­at­ed with an increased risk of pre­dom­i­nant Glea­son 4 pat­tern on rad­i­cal prosta­te­c­to­my spec­i­men.Neuzil­let, Y ; Ray­naud, JP ; Lebret, T ; Pichon, A ; Rad­ules­cu, C ; Molin­ie, V & alHorm Mol Biol Clin Inves­tig201522101–926047422
The Great Imi­ta­tor in Endocrinol­o­gy: A Painful Hypophysi­tis Mim­ic­k­ing a Pitu­itary Tumor.Bricaire, L ; Van Haecke, C ; Lau­rent-Rous­sel, S ; Jrad, G ; Berther­at, J ; Bernier, M & alJ Clin Endocrinol Metab20151002837–4026030326
CIC inac­ti­vat­ing muta­tions iden­ti­fy aggres­sive sub­set of 1p19q codelet­ed gliomas.Gleize, V ; Alen­torn, A ; Con­nen de Kéril­lis, L ; Labus­sière, M ; Nadarad­jane, AA ; Mund­willer, E & alAnn Neu­rol201578355–7426017892
Co-acti­va­tion of AMPK and mTORC1 Induces Cyto­tox­i­c­i­ty in Acute Myeloid Leukemia.Sujobert, P ; Poulain, L ; Paubelle, E ; Zyl­ber­sztejn, F ; Gre­nier, A ; Lam­bert, M & alCell Rep2015111446–5726004183
(99m)Tc-HMDP scintig­ra­phy rec­ti­fies wrong diag­no­sis of AL amy­loi­do­sis.Galat, A ; Van Der Gucht, A ; Colom­bat, M ; Attias, D ; Itti, E ; Meignan, M & alJ Nucl Car­di­ol201522853–726002815
A 16-gene assay to pre­dict recur­rence after surgery in localised renal cell car­ci­no­ma: devel­op­ment and val­i­da­tion stud­ies.Rini, B ; God­dard, A ; Kneze­vic, D ; Mad­dala, T ; Zhou, M ; Aydin, H & alLancet Oncol201516676–8525979595
α‑Defensins par­tial­ly pro­tect human neu­trophils against Pan­ton-Valen­tine leuko­cidin pro­duced by Staphy­lo­coc­cus aureus.Car­dot-Mar­tin, E ; Casaleg­no, JS ; Badiou, C ; Dauwalder, O ; Keller, D ; Prévost, G & alLett Appl Micro­bi­ol201561158–6425963798
Pos­i­tive sur­gi­cal mar­gins after rad­i­cal prosta­te­c­to­my: What should we care about?Pet­te­nati, C ; Neuzil­let, Y ; Rad­ules­cu, C ; Hervé, JM ; Molin­ié, V ; Lebret, TWorld J Urol2015331973–825939539
Elab­o­ra­tion of a con­sen­su­al def­i­n­i­tion of de-esca­la­tion allow­ing a rank­ing of β‑lactams.Weiss, E ; Zahar, JR ; Lesprit, P ; Ruppe, E ; Leone, M ; Chas­tre, J & alClin Micro­bi­ol Infect201521649.e1-1025882363
Chor­doid gliomas of the third ven­tri­cle share TTF‑1 expres­sion with organum vas­cu­lo­sum of the lam­i­na ter­mi­nalis.Bielle, F ; Vil­la, C ; Giry, M ; Berge­mer-Fou­quet, AM ; Poliv­ka, M ; Vasil­je­vic, A & alAm J Surg Pathol201539948–5625786084
[Tetraspanins: a new tar­get for antian­gio­genic ther­a­py?].Vasse, M ; Col­in, S ; Guil­main, W ; Cre­off, E ; Muraine, M ; Van­nier, JP & alAnn Pharm Fr201573100–725745942
Mol­e­c­u­lar iden­ti­fi­ca­tion of Muco­rales in human tis­sues: con­tri­bu­tion of PCR elec­tro­spray-ion­iza­tion mass spec­trom­e­try.Alanio, A ; Gar­cia-Her­moso, D ; Merci­er-Delarue, S ; Lanternier, F ; Gits-Musel­li, M ; Menot­ti, J & alClin Micro­bi­ol Infect201521594.e1‑525726039
X‑linked acrogi­gan­tism syn­drome: clin­i­cal pro­file and ther­a­peu­tic respons­es.Beck­ers, A ; Lodish, MB ; Triv­el­lin, G ; Ros­to­myan, L ; Lee, M ; Faucz, FR & alEndocr Relat Can­cer201522353–6725712922
Post­pre­scrip­tion review improves in-hos­pi­tal antibi­ot­ic use: a mul­ti­cen­ter ran­dom­ized con­trolled tri­al.Lesprit, P ; de Pont­far­cy, A ; Espos­i­to-Farese, M ; Fer­rand, H ; Mainar­di, JL ; Lafau­rie, M & alClin Micro­bi­ol Infect201521180.e1‑725658564
Boost­ed lopinavir- ver­sus boost­ed atazanavir-con­tain­ing reg­i­mens and immuno­log­ic, viro­log­ic, and clin­i­cal out­comes: a prospec­tive study of HIV-infect­ed indi­vid­u­als in high-income coun­tries.Cain, LE ; Phillips, A ; Olson, A ; Sabin, C ; Jose, S ; Jus­tice, A & alClin Infect Dis2015601262–825567330
Extra­n­odal lym­phoma of the head and neck: a 67-case series.Picard, A ; Cardinne, C ; Denoux, Y ; Wag­n­er, I ; Chabolle, F ; Bach, CAEur Ann Otorhi­no­laryn­gol Head Neck Dis201513271–525553969
[Pro­teomics, a new tool for an accu­rate typ­ing of amy­loi­do­sis].Colom­bat, M ; Holifan­ja­ni­aina, S ; Oni­fara­soa­ni­aina, S ; Valleix, S ; Maison­neuve, H ; Kahn, JERev Med Interne201536346–5125544147
Eculizum­ab for treat­ment of rapid­ly pro­gres­sive C3 glomeru­lopa­thy.Le Quin­trec, M ; Lionet, A ; Kan­del, C ; Bour­don, F ; Gnem­mi, V ; Colom­bat, M & alAm J Kid­ney Dis201565484–925530108
Liv­er-relat­ed deaths in HIV-infect­ed patients between 1995 and 2010 in France: the Mor­tavic 2010 study in col­lab­o­ra­tion with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mor­tal­ité 2010 sur­vey.Rosen­thal, E ; Rous­sil­lon, C ; Salmon-Céron, D ; Geor­get, A ; Hénard, S ; Huleux, T & alHIV Med201516230–925522874
Antibi­ot­ic treat­ment for 6 weeks ver­sus 12 weeks in patients with pyo­genic ver­te­bral osteomyelitis: an open-label, non-infe­ri­or­i­ty, ran­domised, con­trolled tri­al.Bernard, L ; Dinh, A ; Ghout, I ; Simo, D ; Zeller, V ; Issar­tel, B & alLancet2015385875–8225468170
Com­mu­ni­ty-acquired meti­cillin-resis­tant Staphy­lo­coc­cus aureus strain USA300 resists staphy­lo­coc­cal pro­tein A mod­u­la­tion by antibi­otics and antimi­cro­bial pep­tides.Car­dot Mar­tin, E ; Michel, A ; Ray­nal, B ; Badiou, C ; Lau­rent, F ; Van­de­nesch, F & alInt J Antimi­crob Agents20154519–2425450803
Prog­nos­tic Rel­e­vance of His­to­mol­e­c­u­lar Clas­si­fi­ca­tion of Dif­fuse Adult High-Grade Gliomas with Necro­sis.Figarel­la-Branger, D ; Mokhtari, K ; Col­in, C ; Uro-Coste, E ; Jou­vet, A ; Dehais, C & alBrain Pathol201525418–2825407774
SWI/SNF chro­matin remod­el­ing and human malig­nan­cies.Masli­ah-Plan­chon, J ; Bièche, I ; Guine­bretière, JM ; Bour­deaut, F ; Delat­tre, OAnnu Rev Pathol201510145–7125387058
In vivo and in vit­ro sen­si­tiv­i­ty of blas­tic plas­ma­cy­toid den­drit­ic cell neo­plasm to SL-401, an interleukin‑3 recep­tor tar­get­ed bio­log­ic agent.Angelot-Delet­tre, F ; Rog­gy, A ; Frankel, AE ; Lamarthee, B ; Seilles, E ; Biich­le, S & alHaema­to­log­i­ca2015100223–3025381130
Trends in phar­ma­cists” med­ica­tion order review in French hos­pi­tals from 2006 to 2009: analy­sis of phar­ma­cists” inter­ven­tions from the Act-IP© web­site obser­va­to­ry.Bedouch, P ; Sylvoz, N ; Charpi­at, B ; Juste, M ; Roubille, R ; Rose, FX & alJ Clin Pharm Ther20154032–4025303720
[Lack of bioavail­abil­i­ty of gener­ic lopinavir/ritonavir not pre­qual­i­fied by WHO mar­ket­ed in Africa (Con­go Braz­zav­ille)].Cama­ra, S ; Zuc­man, D ; Vasse, M ; Goud­jo, A ; Guil­lard, E ; Pey­tavin, GBull Soc Pathol Exot201510846–825256250
Velopha­ryn­geal func­tion after free tho­ra­codor­sal artery per­fo­ra­tor flap in lat­er­al and supe­ri­or oropha­ryn­geal can­cer.Bach, CA ; Wag­n­er, I ; Pig­ot, JL ; Guth, A ; Denoux, Y ; Chabolle, FEur Arch Otorhi­no­laryn­gol20152723019–2625240380
[Improve­ment of pneu­mo­coc­cal immu­niza­tion cov­er­age in old­er patients].Kryp­ci­ak, S ; Liuu, E ; Vin­cenot, M ; Lan­delle, C ; Lesprit, P ; Car­i­ot, MA & alRev Med Interne201536243–724973294
Retour haut de page